Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile



Phone: n/a Fax: n/a


AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs approximately 25,000 people worldwide and markets medicines in more than 170 countries.

 Key Statistics

Ownership: Public

Web Site: AbbVie
Symbol: ABBV


 Company News
AbbVie (ABBV) To Host Second-Quarter Earnings Conference Call 7/23/2014 1:27:22 PM
AbbVie (ABBV) Finally Clinches Shire For $54 Billion 7/18/2014 6:53:49 AM
AbbVie (ABBV) Executive John G. Poulos Named 2014 Frank Barnes Mentor Award Winner By The Licensing Executives Society (U.S.A. & Canada), Inc. 7/16/2014 9:48:57 AM
AbbVie (ABBV) Announces Inaugural Week Of Possibilities Volunteer Program To Support Six Schools In North Chicago, Ill., And Worcester, Mass. 7/16/2014 9:40:07 AM
Shire Ready To Bow To AbbVie (ABBV)'s Increased $53 Billion Offer 7/14/2014 7:41:25 AM
AbbVie (ABBV), Shire Close In On $53 Billion Merger Deal 7/14/2014 7:39:24 AM
AbbVie (ABBV) Forced To Retract Claims Of Shire Investor Support 7/9/2014 7:36:17 AM
Shire plc: Statement re: AbbVie (ABBV) Announcement 7/8/2014 9:35:19 AM
AbbVie (ABBV) Makes Fourth Bid For Shire, Hikes Bid To $51 Billion 7/8/2014 7:32:46 AM
AbbVie (ABBV) To Dispatch Research Chief Jim Sullivan To London 7/7/2014 7:30:14 AM